NCT04077099 2026-03-18A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung CancerRegeneron PharmaceuticalsPhase 1/2 Recruiting231 enrolled